Scientists at the Leibniz Institute for Immunotherapy in Germany have discovered that the LMO4 gene can enhance the stemness of T cells, increasing...
Vous n'êtes pas connecté
Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukaemia a humanised animal model. The results mark a key step in the realization of ePCs as therapies to treat cancer, auto-immune disorders, and protein deficiency disorders. The results appear July 2 in the journal Molecular Therapy. [...]
Scientists at the Leibniz Institute for Immunotherapy in Germany have discovered that the LMO4 gene can enhance the stemness of T cells, increasing...
Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like...
For decades, researchers have worked to develop therapies that can prime the immune system to recognize and attack proteins on the surface of tumor...
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other cells, such as cancer...
The genes responsible for inborn errors of immunity (disorders affecting immune system function) and metabolism (disorders of the processes that...
Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. While successful in some types...
Symptoms of Alzheimer’s disease include memory loss, confusion, and speech problems. They are associated with the formation of aggregates...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 8, 2024-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering...
After promising results in monkeys, scientists plan to test the new treatment in a few people with H.I.V.
A recent study published in Science Immunology revealed that inherited immune and metabolism disorders are more similar than previously understood....